In a significant advancement for point-of-care medical diagnostics, a team of researchers from the University of California, Los Angeles, has introduced a deep learning-enhanced, paper-based vertical flow assay capable of detecting cardiac troponin I with high sensitivity. Troponin I is a protein released when the heart muscle has been damaged. The innovative assay integrates deep learning algorithms with cutting-edge nanoparticle amplification chemistry and could enable access to rapid and reliable cardiac diagnostics, particularly in resource-limited settings. "Our goal was to design a system that could be used not only in hospitals but also in clinics, pharmacies, and even in ambulances," said Gyeo-Re Han, one of the scientists involved in this study.
An official website of the United States government.